LFD-200

N/A

Report date: 2026/03/24 20:00:35

Base Information

Drug NameLFD-200
Drug Alias NameLFD-200
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-V-domain Ig suppressor of T-cell activation
TargetsV-domain Ig suppressor of T-cell activation
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkrainePolandAustralia +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLifordi Immunotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLifordi Immunotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A